1-4 of 4
Christopher L Cubitt, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Selinexor in Combination with Daunorubicin and Cytarabine in Patients with Newly Diagnosed Poor-Risk Acute Myeloid Leukemia

Kendra L. Sweet, MD, Rami S. Komrokji, MD, Eric Padron, MD, Christopher L Cubitt, PhD, Leyla Khavarian, Alan F List, MD, David Sallman, MD, Daniel Sullivan, Julio C Chavez, MD, Bijal D. Shah, MD, Jeffrey E. Lancet, MD
Journal: Blood
Blood (2016) 128 (22): 4040.
https://doi.org/10.1182/blood.V128.22.4040.4040
Published: 2016
Journal Articles

A Phase 1/2 Study of the Second Generation Selective Inhibitor of Nuclear Export (SINE) Compound, KPT-8602, in Patients with Relapsed Refractory Multiple Myeloma

R. Frank Cornell, MD MS, Adriana C Rossi, MD, MSc, Rachid Baz, MD, Craig C Hofmeister, Chaim Shustik, MD, Joshua R. Richter, MD, Christine Chen, MD, Dan T. Vogl, MD, Sharon Shacham, PhD MBA, Erkan Baloglu, PhD MBA, William Senapedis, PhD, Joel Ellis, PhD, Sharon Friedlander, PhD, Cassandra Choe-Juliak, MD, Christopher L Cubitt, PhD, Joel G Turner, PhD, Daniel Sullivan, MD MS, Michael Kauffman, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4509.
https://doi.org/10.1182/blood.V128.22.4509.4509
Published: 2016
Journal Articles

Comprehensive Inflammatory Cytokine Profiling Identifies IL-8/CXCL8 As Elevated, Associated with Proliferative Features, and Independently Prognostic in Chronic Myelomonocytic Leukemia (CMML)

Sandrine Niyongere, MD, Nolwenn Lucas, Samir Sansil, Christopher L Cubitt, PhD, Maria E. Balasis, Jodi Kroeger, Qing Zhang, MD, John J Ceremsak, Elliot Stieglitz, MD, YuLong Zhao, PhD, Markus Ball, PhD, Rami S. Komrokji, MD, Alan F List, MD, Valeria Santini, MD, Eric Solary, Eric Padron, MD
Journal: Blood
Blood (2016) 128 (22): 109.
https://doi.org/10.1182/blood.V128.22.109.109
Published: 2016
Journal Articles

Next Generation XPO1 Inhibitor KPT-8602 for the Treatment of Drug-Resistant Multiple Myeloma

Joel G Turner, PhD, Jana L Dawson, BS, Christopher L Cubitt, PhD, Erkan Baluglo, PhD, Steven Grant, MD, Yun Dai, PhD, Kenneth H Shain, MD PhD, William S. Dalton, PhD MD, Sharon Shacham, William Senapedis, PhD, Daniel M Sullivan, MD
Journal: Blood
Blood (2015) 126 (23): 1818.
https://doi.org/10.1182/blood.V126.23.1818.1818
Published: 2015